Weekly Recap

NeurologyLive Weekly Recap

Each week on Saturday morning, the NeurologyLive^® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.

BIIB122 Discontinued in LRRK2 Parkinson Disease, Pimavanserin and PTSD-Associated Insomnia, Obstructive Sleep Apnea Following VNS

BIIB122 Discontinued in LRRK2 Parkinson Disease, Pimavanserin and PTSD-Associated Insomnia, Obstructive Sleep Apnea Following VNS

NeurologyLive® Staff

Neurology News Network for the week ending June 10, 2023. [WATCH TIME: 3 minutes]

CMS Adds Coverage for Antiamyloid Therapies, NDA for Migraine Agent Accepted, INTUNE Study Ahead of Schedule

CMS Adds Coverage for Antiamyloid Therapies, NDA for Migraine Agent Accepted, INTUNE Study Ahead of Schedule

NeurologyLive® Staff

Neurology News Network for the week ending June 2, 2023. [WATCH TIME: 3 minutes]

Wave Discontinues ALS Agent WVE-004, FDA Pushes Back Decision on SRP-9001, Asundexian Receives Fast Track Designation

Wave Discontinues ALS Agent WVE-004, FDA Pushes Back Decision on SRP-9001, Asundexian Receives Fast Track Designation

NeurologyLive® Staff

Neurology News Network for the week ending May 27, 2023. [WATCH TIME: 3 minutes]

Treg Treatment Sustains Cognition in AD, FDA Approves Spinal Cord Stimulation Systems, Soticlestat Reduces Seizures in CDD

Treg Treatment Sustains Cognition in AD, FDA Approves Spinal Cord Stimulation Systems, Soticlestat Reduces Seizures in CDD

NeurologyLive® Staff

Neurology News Network for the week ending May 20, 2023. [WATCH TIME: 4 minutes]

CVD Risk in Epilepsy Increases Dementia Risk, Teriflunomide in RIS, FDA Clears Dry-Sensor EEG Headset

CVD Risk in Epilepsy Increases Dementia Risk, Teriflunomide in RIS, FDA Clears Dry-Sensor EEG Headset

NeurologyLive® Staff

Neurology News Network for the week ending May 13, 2023. [WATCH TIME: 4 minutes]

Zavegepant Effective Regardless of Aura Status, FDA Approves Extended-Release Sodium Oxybate, Mediterranean Diet Adherence Improves MS Cognition

Zavegepant Effective Regardless of Aura Status, FDA Approves Extended-Release Sodium Oxybate, Mediterranean Diet Adherence Improves MS Cognition

NeurologyLive® Staff

Neurology News Network for the week ending May 6, 2023. [WATCH TIME: 4 minutes]

Atogepant's Impact on Chronic Migraine, LD/CD Intra-Oral Pump Improves ON Time, Ravulizumab Effective in NMOSD Subgroups

Atogepant's Impact on Chronic Migraine, LD/CD Intra-Oral Pump Improves ON Time, Ravulizumab Effective in NMOSD Subgroups

NeurologyLive® Staff

April 30th 2023

Neurology News Network for the week ending April 30, 2023. [WATCH TIME: 4 minutes]

DEA Rules Fenfluramine No Longer Controlled Substance, Positive FDA ADComm Meeting of Brexpiprazole, Antiamyloid Drugs Accelerate Brain Atrophy

DEA Rules Fenfluramine No Longer Controlled Substance, Positive FDA ADComm Meeting of Brexpiprazole, Antiamyloid Drugs Accelerate Brain Atrophy

NeurologyLive® Staff

April 22nd 2023

Neurology News Network for the week ending April 22, 2023. [WATCH TIME: 4 minutes]

EASEE Device Reduces Seizures in DRE, Narcolepsy Incidence Increased During H1N1 Pandemic, Trial of GTX-104 Moving Forward

EASEE Device Reduces Seizures in DRE, Narcolepsy Incidence Increased During H1N1 Pandemic, Trial of GTX-104 Moving Forward

NeurologyLive® Staff

April 15th 2023

Neurology News Network for the week ending April 15, 2023. [WATCH TIME: 4 minutes]

Remternetug Significantly Reduces Amyloid Plaque, Phase 3 INTUNE Study Accelerated, Pitolisant Approved for Pediatric Narcolepsy by EMA

Remternetug Significantly Reduces Amyloid Plaque, Phase 3 INTUNE Study Accelerated, Pitolisant Approved for Pediatric Narcolepsy by EMA

NeurologyLive® Staff

Neurology News Network for the week ending April 8, 2023. [WATCH TIME: 4 minutes]

Lecanemab Adds Quality-Adjusted Life Years, FDA to Hold AdComm Meeting Over NurOwn, SYMBYX Neuro Improves PD Symptoms

Lecanemab Adds Quality-Adjusted Life Years, FDA to Hold AdComm Meeting Over NurOwn, SYMBYX Neuro Improves PD Symptoms

NeurologyLive® Staff

Neurology News Network for the week ending April 1, 2023. [WATCH TIME: 4 minutes]

Efgartigimod Effective Across Subgroups, FDA to Hold AdComm Meeting on SRP-9001, Reboxetine Demonstrates Positive Effect on Obstructive Sleep Apnea

Efgartigimod Effective Across Subgroups, FDA to Hold AdComm Meeting on SRP-9001, Reboxetine Demonstrates Positive Effect on Obstructive Sleep Apnea

March 25th 2023

Neurology News Network for the week ending March 25, 2023. [WATCH TIME: 3 minutes]

Cognitive and Functional Differences in Parkinson, FDA Lifts Hold on IkT-148009, Solanezumab Shows No Impact on Cognitive Decline

Cognitive and Functional Differences in Parkinson, FDA Lifts Hold on IkT-148009, Solanezumab Shows No Impact on Cognitive Decline

NeurologyLive® Staff

March 18th 2023

Neurology News Network for the week ending March 18, 2023. [WATCH TIME: 4 minutes]

Efgartigimod Improves HR-Related Quality of Life, Traditional Approval for Lecanemab Pending, Satrlizumab Benefits NMOSD After Switching

Efgartigimod Improves HR-Related Quality of Life, Traditional Approval for Lecanemab Pending, Satrlizumab Benefits NMOSD After Switching

NeurologyLive® Staff

March 11th 2023

Neurology News Network for the week ending March 11, 2023. [WATCH TIME: 3 minutes]

Gene Therapy ST-920 Shows Benefit in Fabry, Intermittent Calorie Restriction in Multiple Sclerosis, High Economic Burden Identified in NMOSD

Gene Therapy ST-920 Shows Benefit in Fabry, Intermittent Calorie Restriction in Multiple Sclerosis, High Economic Burden Identified in NMOSD

NeurologyLive® Staff

Neurology News Network for the week ending March 4, 2023. [WATCH TIME: 3 minutes]

Sodium Oxybate Alters Sleep Structure, FDA Approves Deutetrabenazine, Associations of Stroke Decreased With Age

Sodium Oxybate Alters Sleep Structure, FDA Approves Deutetrabenazine, Associations of Stroke Decreased With Age

NeurologyLive® Staff

February 25th 2023

Neurology News Network for the week ending February 26, 2022. [WATCH TIME: 3 minutes]

CNM-Au8 Impacts Neuronal Structural Integrity, Mobile Stroke Units and Direct Transfer to Angiography, Cognitive Impairments Higher in RBD Before Parkinson Disease

CNM-Au8 Impacts Neuronal Structural Integrity, Mobile Stroke Units and Direct Transfer to Angiography, Cognitive Impairments Higher in RBD Before Parkinson Disease

NeurologyLive® Staff

February 18th 2023

Neurology News Network for the week ending February 18, 2023. [WATCH TIME: 4 minutes]

PHOENIX Study Meets Enrollment, Atogepant and Ubrogepant Safe, ABATE Trial Highlights Targeted Response of Alzheimer Vaccine

PHOENIX Study Meets Enrollment, Atogepant and Ubrogepant Safe, ABATE Trial Highlights Targeted Response of Alzheimer Vaccine

NeurologyLive® Staff

February 11th 2023

Neurology News Network for the week ending February 11, 2023. [WATCH TIME: 3 minutes]

New Diagnostic Criteria Established for MOGAD, FDA Approves Proclaim XR SCS System, Clinical Hold on IKT-148009 Lifted

New Diagnostic Criteria Established for MOGAD, FDA Approves Proclaim XR SCS System, Clinical Hold on IKT-148009 Lifted

NeurologyLive® Staff

February 4th 2023

Neurology News Network for the week ending February 4, 2023. [WATCH TIME: 4 minutes]

Evoke SCS System Shows Positive 36-Month Results, FDA Lifts Hold on FORTIS, Complete Response Letter Issued for Donanemab

Evoke SCS System Shows Positive 36-Month Results, FDA Lifts Hold on FORTIS, Complete Response Letter Issued for Donanemab

NeurologyLive® Staff

January 28th 2023

Neurology News Network for the week ending January 28, 2023. [WATCH TIME: 4 minutes]

COVID-19 Vaccine and Potential Stroke Concern, Associations Between AEDs and Incident Parkinson, FDA Accepts sBLA for DaxibolinumtoxinA

COVID-19 Vaccine and Potential Stroke Concern, Associations Between AEDs and Incident Parkinson, FDA Accepts sBLA for DaxibolinumtoxinA

NeurologyLive® Staff

January 21st 2023

Neurology News Network for the week ending January 21, 2022. [WATCH TIME: 3 minutes]

24-Hour Levodopa Solution Improves ON Time, Eisai Submits sBLA for Traditional Approval of Lecanemab, Rare Case of Seronegative NMOSD Identified

24-Hour Levodopa Solution Improves ON Time, Eisai Submits sBLA for Traditional Approval of Lecanemab, Rare Case of Seronegative NMOSD Identified

NeurologyLive® Staff

January 14th 2023

Neurology News Network for the week ending January 14, 2022. [WATCH TIME: 4 minutes]

FDA Approves Essential Tremor Treatment, Alzheimer's Association Files Request to CMS, Duchenne Therapy ENTR-601-44 Placed on Hold

FDA Approves Essential Tremor Treatment, Alzheimer's Association Files Request to CMS, Duchenne Therapy ENTR-601-44 Placed on Hold

NeurologyLive® Staff

December 31st 2022

Neurology News Network for the week ending December 31, 2022. [WATCH TIME: 3 minutes]

WVE-N531's Impact on Exon Skipping, PROs Improved With Early DMT Initiation, Carbon Dioxide Improves Insomnia Sleep

WVE-N531's Impact on Exon Skipping, PROs Improved With Early DMT Initiation, Carbon Dioxide Improves Insomnia Sleep

NeurologyLive® Staff

December 24th 2022

Neurology News Network for the week ending December 24, 2022. [WATCH TIME: 4 minutes]

Genetic Links to PML Identified, MARINA Trial Findings Announced, Educational Videos Improve CPAP Adherence

Genetic Links to PML Identified, MARINA Trial Findings Announced, Educational Videos Improve CPAP Adherence

NeurologyLive® Staff

December 17th 2022

Neurology News Network for the week ending December 17, 2022. [WATCH TIME: 4 minutes]

Communication Critical for Dravet Syndrome, DNL343 to Enter HEALEY ALS Trial, Combination of Seizures and Dementia Leads to Worse Outcomes

Communication Critical for Dravet Syndrome, DNL343 to Enter HEALEY ALS Trial, Combination of Seizures and Dementia Leads to Worse Outcomes

NeurologyLive® Staff

December 10th 2022

Neurology News Network for the week ending December 10, 2022. [WATCH TIME: 4 minutes]

Donanemab Outperforms Aducanumab in Amyloid Clearance, FDA Grants Priority Review to SRP-9001, Atogepant Improves PROs

Donanemab Outperforms Aducanumab in Amyloid Clearance, FDA Grants Priority Review to SRP-9001, Atogepant Improves PROs

NeurologyLive® Staff

December 3rd 2022

Neurology News Network for the week ending December 3, 2022. [WATCH TIME: 3 minutes]

Aquatic Therapy Improves MS Fatigue, MS Disease Pathology Not Defined by Courses, Rituximab Shows Positive Effect in Myasthenia Gravis

Aquatic Therapy Improves MS Fatigue, MS Disease Pathology Not Defined by Courses, Rituximab Shows Positive Effect in Myasthenia Gravis

NeurologyLive® Staff

November 26th 2022

Neurology News Network for the week ending November 26, 2022. [WATCH TIME: 4 minutes]

Positive Results of STK-001 in Dravet, Zavegepant Meets Primary End Points, FDA Accepts NDA of Zilucoplan for Myasthenia Gravis

Positive Results of STK-001 in Dravet, Zavegepant Meets Primary End Points, FDA Accepts NDA of Zilucoplan for Myasthenia Gravis

NeurologyLive® Staff

November 19th 2022

Neurology News Network for the week ending November 19, 2022. [WATCH TIME: 3 minutes]

FDA Rejects BLA for NurOwn, Simvastatin Futile as DMT for Parkinson, Music Potentially Improves Insomnia Symptoms

FDA Rejects BLA for NurOwn, Simvastatin Futile as DMT for Parkinson, Music Potentially Improves Insomnia Symptoms

NeurologyLive® Staff

November 12th 2022

Neurology News Network for the week ending November 12, 2022. [WATCH TIME: 4 minutes]

<1 2 3 4 5 6 7 8

...

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.